XML 172 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands
Total
Parent
Common stock
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2023     51,770          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     410          
Common stock issued for ESPP purchases (in shares)     119          
Common stock sold through offerings (in shares)     0          
Ending balance (in shares) at Sep. 30, 2024     52,299          
Beginning balance, treasury stock (in shares) at Dec. 31, 2023       6,356        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       0        
Tax withholding upon vesting of employee stock awards (in shares)       126        
Ending balance, treasury stock (in shares) at Sep. 30, 2024       6,482        
Beginning balance at Dec. 31, 2023     $ 5,000 $ (166,345,000) $ 1,007,649,000 $ (481,671,000) $ (506,000) $ 0
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation to employees and directors         16,384,000      
Common stock issued for ESPP purchases         1,472,000      
Common stock sold through offerings     0   0      
Consolidated net loss $ (177,536,000)         (177,536,000)    
Net other comprehensive income 12,000           12,000  
Repurchases of common stock       0        
Tax withholding upon vesting of employee stock awards       (3,271,000)        
Proceeds from security token offering, net               0
Net loss attributable to noncontrolling interests 0             0
Ending balance at Sep. 30, 2024 196,193,000 $ 196,193,000 $ 5,000 $ (169,616,000) 1,025,505,000 (659,207,000) (494,000) 0
Beginning balance (in shares) at Jun. 30, 2024     52,230          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     6          
Common stock issued for ESPP purchases (in shares)     63          
Common stock sold through offerings (in shares)     0          
Ending balance (in shares) at Sep. 30, 2024     52,299          
Beginning balance, treasury stock (in shares) at Jun. 30, 2024       6,480        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       0        
Tax withholding upon vesting of employee stock awards (in shares)       2        
Ending balance, treasury stock (in shares) at Sep. 30, 2024       6,482        
Beginning balance at Jun. 30, 2024     $ 5,000 $ (169,595,000) 1,018,619,000 (598,177,000) (498,000) 0
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation to employees and directors         6,349,000      
Common stock issued for ESPP purchases         537,000      
Common stock sold through offerings     0   0      
Consolidated net loss (61,030,000)         (61,030,000)    
Net other comprehensive income 4,000           4,000  
Repurchases of common stock       0        
Tax withholding upon vesting of employee stock awards       (21,000)        
Proceeds from security token offering, net               0
Net loss attributable to noncontrolling interests 0             0
Ending balance at Sep. 30, 2024 $ 196,193,000 196,193,000 $ 5,000 $ (169,616,000) 1,025,505,000 (659,207,000) (494,000) 0
Increase (Decrease) in Stockholders' Equity                
Common stock, shares outstanding (in shares)     45,817          
Common stock, shares outstanding (in shares) 53,069              
Beginning balance (in shares) at Dec. 31, 2024     59,560          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     341          
Common stock issued for ESPP purchases (in shares)     138          
Common stock sold through offerings (in shares)     12,432          
Ending balance (in shares) at Sep. 30, 2025     72,471          
Beginning balance, treasury stock (in shares) at Dec. 31, 2024 6,491     6,491        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       903        
Tax withholding upon vesting of employee stock awards (in shares)       93        
Ending balance, treasury stock (in shares) at Sep. 30, 2025 7,487     7,487        
Beginning balance at Dec. 31, 2024 $ 162,732,000   $ 5,000 $ (169,676,000) 1,072,869,000 (740,466,000) 0 0
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation to employees and directors         8,002,000      
Common stock issued for ESPP purchases         683,000      
Common stock sold through offerings     2,000   101,688,000      
Consolidated net loss (63,746,000)         (63,746,000)    
Net other comprehensive income 0           0  
Repurchases of common stock (6,200,000)     (6,218,000)        
Tax withholding upon vesting of employee stock awards       (544,000)        
Proceeds from security token offering, net               341,000
Net loss attributable to noncontrolling interests 0             0
Ending balance at Sep. 30, 2025 $ 202,940,000 202,599,000 $ 7,000 $ (176,438,000) 1,183,242,000 (804,212,000) 0 341,000
Beginning balance (in shares) at Jun. 30, 2025     64,322          
Increase (Decrease) in Stockholders' Equity                
Common stock issued upon vesting of restricted stock (in shares)     2          
Common stock issued for ESPP purchases (in shares)     47          
Common stock sold through offerings (in shares)     8,100          
Ending balance (in shares) at Sep. 30, 2025     72,471          
Beginning balance, treasury stock (in shares) at Jun. 30, 2025       6,917        
Increase (Decrease) in Stockholders' Equity                
Repurchases of common stock (in shares)       570        
Tax withholding upon vesting of employee stock awards (in shares)       0        
Ending balance, treasury stock (in shares) at Sep. 30, 2025 7,487     7,487        
Beginning balance at Jun. 30, 2025     $ 6,000 $ (171,526,000) 1,102,079,000 (799,691,000) 0 337,000
Increase (Decrease) in Stockholders' Equity                
Stock-based compensation to employees and directors         3,522,000      
Common stock issued for ESPP purchases         174,000      
Common stock sold through offerings     1,000   77,467,000      
Consolidated net loss $ (4,521,000)         (4,521,000)    
Net other comprehensive income 0           0  
Repurchases of common stock (4,900,000)     (4,907,000)        
Tax withholding upon vesting of employee stock awards       (5,000)        
Proceeds from security token offering, net               4,000
Net loss attributable to noncontrolling interests 0             0
Ending balance at Sep. 30, 2025 $ 202,940,000 $ 202,599,000 $ 7,000 $ (176,438,000) $ 1,183,242,000 $ (804,212,000) $ 0 $ 341,000
Increase (Decrease) in Stockholders' Equity                
Common stock, shares outstanding (in shares) 64,984   64,984